Genomic data governance
Pseudonymised subjects, consent, samples, genomic metadata, provenance and traceability in one governed environment.
UESE LIFE SCIENCES & PRECISION MEDICINE
A digital platform for hospitals, research institutes, universities, NGS laboratories, biotech and consortia that need to govern data, samples, bioinformatics workflows and AI activities with traceability, security and human scientific oversight.
Pseudonymised subjects, consent, samples, genomic metadata, provenance and traceability in one governed environment.
Sequencing, analyses, HLA, RNA expression, normalisation and bioinformatics pipelines with transparent states and accountability.
Multi-organisation workspace for centres, laboratories, universities and consortia with project- and role-based segregation.
RUO orchestration of AI and bioinformatics with versioning, provenance and mandatory human scientific oversight.
2FA, activity logging, access controls and governance support for GDPR, EHDS and responsible AI.
Evaluation environment using synthetic data only, time-limited access and Superadmin approval for meaningful due diligence.
UESE Precision Bio AI is not designed to replace clinical or laboratory systems. It is designed to make the research journey readable, traceable and governable when multiple datasets, roles and organisations need to work together.
Connect work currently spread across files, email and vertical systems without replacing existing specialist tools.
Link subjects, samples, analyses, pipelines, outputs and reviews to a coherent and auditable history.
Share work across organisations, sites and partners while preserving segregation, accountability and selective visibility.
Start with a controlled pilot and expand only after multidisciplinary validation of utility, risk and integration.
Each step remains linked to project, organisation, user, version and purpose. This supports controlled pilots, multicentre studies and structured collaborations.
Register pseudonymised subjects, consent, samples and sequencing metadata.
Connect files, variants, molecular profiles and versioned bioinformatics pipelines.
Submit RUO outputs and candidates to documented human scientific review.
Share evidence and progress with authorised teams, partners and consortia.
The current configuration is RUO: it does not provide diagnosis, prescriptions or autonomous therapeutic decisions.
Research outputs remain subject to authorised and qualified personnel.
Events, versions, provenance, hashes and reviews support auditability and accountability.
Pseudonymisation, minimisation, access segregation and 2FA are built into the architecture.
The platform supports organisational governance of applicable GDPR, EHDS and responsible-AI requirements.
The DEMO environment is pre-populated with projects, synthetic subjects, samples, sequencing, variants, HLA, RNA expression, pipelines, RUO jobs and reviews. Access is temporary, verified and approved so prospective users can meaningfully assess the workflow without exposing real data.
The published configuration is intended for research use (RUO) and is not presented as a medical device or diagnostic system. Any future regulated intended use would require a separate qualification and compliance pathway.
The Control Plane governs metadata, roles, workflows and auditability. Large files may remain on institutional infrastructure or authorised storage according to the agreed architecture.
Yes. The platform is designed as a governance and orchestration layer and can be prepared for API integrations with LIS, information systems, storage, laboratories and bioinformatics engines.
A controlled DEMO using synthetic data only is available. Requests are verified and approved before temporary credentials are activated.
Request a DEMO or a technical discussion with UESE to assess scope, security, integrations and the adoption model.